Current Status
Price
Get Started
Designed for specialist prescribers and clinicians, this advanced module evaluates the evolving evidence base for medical cannabis across a spectrum of psychiatric disorders.
Learners will examine the role of the endocannabinoid system (ECS) in mood regulation, fear extinction, and stress response. The course reviews clinical data for high-prevalence conditions—including anxiety, depression, and insomnia—as well as neurodevelopmental disorders such as ADHD and ASD.
Each lesson differentiates between randomised controlled trial (RCT) evidence and the growing body of real-world data, providing a balanced perspective on efficacy, safety, and the critical exclusion criteria required to mitigate psychiatric risk.
The course concludes with a practical prescribing framework, addressing formulation selection (oral vs. inhaled), risk stratification for patients with complex histories, and the management of drug-drug interactions.
Duration = 90 mins